Impact of pathogen burden on in-stent restenosis in patients after coronary stent implantation

Chinese Medical Journal

Volumn 118, Issue 21, 2005, Pages 1786-1790

  Niu, Yup Hong ^a   Ge, Jun Bo ^a   Xu, Cong Feng ^a   Shi, Jian Hui ^a   Jin, Xue Juan ^a   Qian, Ju Ying ^a   Zou, Yun Zeng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Infection burden; Restenosis; Stent implantation

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATITIS B; HEPATITIS B VIRUS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; QUANTITATIVE ANALYSIS; RESTENOSIS;

ADULT; AGED; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; HUMANS; INFECTION; MALE; MIDDLE AGED; STENTS;

EID: 27844573311     PISSN: 03666999     EISSN: 03666999     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Landau C, Lange RA, Hillis LD. Percutaneous transluminal coronary angioplasty. N Engl J Med 1994; 330:981-993.
2. The bypass angioplasly revascularization investigation (BARI) investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-225.
3. Kastrati A, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997;30:1428-1436.
4. Moussa I, Moses J, Di Mario C, et al. Stenting after optimal lesion debulking (sold) registry: angiographic and clinical outcome. Circulation 1998;98:1604-1609.
5. Weintraub WS, Stein B, Kosinski A, et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol 1998;31:10-19.
6. Rupprecht HJ, Blankenberg S, Bickel C, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coeonary artery disease. Circulation 2001;104:25-31.
7. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on progression of carotid atherosclerosis. Stroke 2002;33:2581-2586.
8. Khairy P, Rinfret S, Tardif JC, et al. Absence of Association Between Infectious Agents and Endothelial Function in Healthy Young Men. Circulation 2003;107: 1966-1971.
9. Neumann FJ, Kastrati A, Miethke T, et al. Previous cytomegalovirus infection and restenosis after coronary stent placement. Circulation 2001;104:1135-1139
10. Schiele F, Batur MK, Seronde MF, et al. Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study. Heart 2001;85:304-311.
11. Van Belle E, Bauters C, Hubert E, et al. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997;96:1454-1460.
12. Kornowski R, Mintz GS, Kent KM, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997;95:1366-1369.
13. Stein B, Weintraub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous coronary angioplasty. Circulation 1995; 91:979-989.
14. Chen R, Xiong S, Yang Y, et al. The relationship between human cytomegalovirus infection and atherosclerosis development. Mol Cell Biochem 2003; 249:91-96.
15. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;311:711-714.
16. Muhlestein JB, Horne BD, Carlquist JF, et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically-demonstrated coronary artery disease. Circulation 2000;102:1917-1923.
17. Zhu J, Quyyumi AA, Norman JE, et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardio 2000;85:140-146.
18. Zhu J, Nieto FJ, Horne BD, et al. Prospective study of pathogen burden and risk of myocardial infarction and death. Circulation 2001;103:45-51.
19. Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996; 335:624-630.
20. Hayashida K, Tanaka M, Morita H, et al. Chlamydia pneumoniae seropositivity predicts the risk of restenosis after percutaneous transluminal coronary angioplasty. Heart Vessels 2002;16:137-145.
21. Schwartz RS. Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling. Am J Cardiol 1998;81:14E-17E.
22. Almeida-Porada G, Porada CD, Shanley JD, et al. Altered production of GM-CSF and IL-8 in cytomegalovirus-infected, IL-1-primed umbilical cord endothelial cells. Exp Hematol 1997;25:1278-1285.
23. Speir E, Shibutani T, Yu ZX, et al. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res 1996;79:1143-1152.
24. Span AH, van Boven CP, Bruggeman CA. The effect of cytomegalovirus infection on the adherence of polymorphonuclear leucocytes to endothelial cells. Eur J Clin Invest 1989;19:542-548.
25. Vercellotti GM. Effects of viral activation of the vessel wall on inflammation and thrombosis. Blood Coagul Fibrinolysis 1998;9 Suppl 2:S3-S6.
26. Tanaka K, Zou JP, Takeda K, et al. Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation 1999;99:1656-1659.
27. Horne BD, Muhlestein JB, Strobel GG, et al. Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention. Am Heart J 2002; 144:491-500.
28. Forrester JS, Fishbein M, Helfant R, et al. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardio 1991;17:758-769.